Hint mode is switched on Switch off
For swift navigation between sections

Jubilant Pharma
LEI 254900FD7PRU3PQBQB82

PDF download

Choose all Reset all
Download Cancel
Organization name
Jubilant Pharma Limited
Country name
Singapore
Country of registration
Singapore
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
  • M/S&P/F
    *** / *** / ***
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Jubilant Pharma provides solutions to global pharmaceutical customers, offering a wide range of products & services. We are a Company engaged in development, manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, and Allergy Therapy Products. Our services comprise Contract Manufacturing of Sterile Injectables , Ointments, Creams and Liquids. Jubilant Pharma is a subsidiary of Jubilant Life Sciences, an integrated global pharmaceutical and life sciences company, which has been ranked No. 6 amongst the Top 10 global contract manufacturing & services outsourcing players of the pharmaceutical industry (Source: UNCTAD 2011).

Awards

News

26/08/2021 Jubilant Pharma got bondholders' approval for consent solicitation
All organization news

Documentation

IFRS/US GAAP reports

2019
I q eng
II q eng
III q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Latest issues

Show all

Public debt by currencies

Show more Hide

Codes

  • LEI
    254900FD7PRU3PQBQB82
  • SIC
    6719 Holding companies
  • ICB
    4,500 Health Care
  • NAICS
    325,412 Pharmaceutical Preparation Manufacturing
  • UEN
    200506887H
Registration is required to get access.